Home, Philip <br/><br/>
Comment on Abd El Aziz et al., A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients.  [electronic resource] 

 -  Diabetes, obesity & metabolism  02 2017 
 - 304-305 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.12842  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Diabetes Mellitus, Type 2<br/>Glucagon-Like Peptide-1 Receptor<br/>Glycated Hemoglobin--analysis<br/>Humans<br/>Hypoglycemic Agents<br/>Insulins